PUBLICATIONS

ADAP Advocacy published the following issue-specific information:

Quick Links:   Annual Reports | Blogs | Infographics | Issue Papers | Op-Ed's | Public Comments

Annual Reports

2023 Annual Report
2022 Annual Report
2021 Annual Report
2020 Annual Report
2019 Annual Report
2018 Annual Report
2017 Annual Report
2016 Annual Report
2015 Annual Report
2014 Annual Report
2013 Annual Report
2012 Annual Report
2011 Annual Report
2010 Annual Report
2009 Annual Report
2008 Annual Report
2007 Annual Report

Blogs

Go to: adapadvocacyassociation.blogspot.com

Infographics

340B: A Critical Safety Net to Help Patients Access Their Medications - (August 2024)

• En español

Beware of Fraudsters Trying to Buy Your Meds - (June 2024)
Worlds AIDS Day: How to Spot Fake HIV Medicines - (November 2022)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on Southern Black Communities - (November 2020)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on Survivors of Domestic Violence - (November 2020)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on Muslims - (November 2020)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on Transgender Communities - (October 2020)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on Aged 55 and Older & Long-Term Survivors - (October 2020)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on Hispanics/Latinos - (October 2020)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on Rural Communities - (October 2020)
IMPLICATIONS OF CORONAVIRUS: COVID-19's Impact on African Americans - (October 2020)
MENTAL HEALTH: Implications of Health Stigma, Mental Health & HIV/AIDS - (October 2019)
MENTAL HEALTH: Implications of Co-Occurring Diagnosis of Depression and HIV/AIDS - (September 2019)
MENTAL HEALTH: Implications of Co-Occurring Diagnosis of a Mental Condition and HIV/AIDS - (August 2019)
CORRECTIONAL HEALTH: Improving Access to Care Among Formerly Incarcerated Populations Living with HIV/AIDS under the AIDS Drug Assistance Program - (August 2018)
TRANSGENDER HEALTH: Improving Access to Care Among Transgender Men & Women Living with HIV/AIDS under the AIDS Drug Assistance Program - (April 2017)

Issue Papers

The 340B Drug Pricing Program and its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities

• En español

HIV LONG-ACTING INJECTABLES: Patient Access Considerations for Injectable HIV Therapies & Injectable HIV Pre-Exposure Prophylaxis - (June 2024)

• Executive Summary (1-page)

HIV LONG-ACTING AGENTS: Policy Considerations for Injectable Therapies under the Ryan White HIV/AIDS Program & State AIDS Drug Assistance Programs - (August 2022)

• Cover Letter - "The Future is Now – Welcome to the Age of Injectables"
• Executive Summary (2-pages)

CORRECTIONAL HEALTH: Improving Access to Care Among Formerly Incarcerated Populations with HIV/AIDS under the AIDS Drug Assistance Program (ADAP): Model Policy for Ryan White/ADAPs Serving Former Inmates - (April 2019)

TRANSGENDER HEALTH: Improving Access to Care Among Transgender Men & Women Living with HIV/AIDS under the AIDS Drug Assistance Program: Model Policy for Ryan White/ADAPs Serving Transgender Clients - (April 2017)

• 10 Tips for Working with TGIQ* Patients

THE SOUTHERN EPIDEMIC: Are the South's cultural, political and societal barriers making it difficult for public health programs, such as the AIDS Drug Assistance Programs, to function effectively in this region? - (May 2014)

THE INTERNATIONAL vs. NATIONAL DEBATE: Is the President's Emergency Plan for AIDS Relief (PEPFAR) international commitment to combating HIV/AIDS succeeding at the expense of those people living with the disease in the United States? - (April 2009)

Op-Ed's

340B HYPOCRISY: The inconvenient truth behind why we need to reform this vital safety net program - (September 24, 2023)
What’s Needed to Fix a Vital Drug Discount Program - (June 7, 2023)
The Politics of Public Health - (April 3, 2023)
It Is Time to Advocate for the Patient - (April 12, 2021)
How Drug Imports Can Endanger Patients - (November 1, 2020)
Imported Medication Might Be Fake - (March 6, 2019)
Drug Importation Policy is a Hard Pill to Swallow - Published in the Washington Blade (August 2017)
The Politics of ADAP - Published in Achieve (2008)

Public Comments

RE: Testimony in support of adding Cabenuva to the drug formulary under the Texas AIDS Drug Assistance Program - (July 9, 2024)
RE: Testimony in opposition to Connecticut Senate Bill No. 8 (“AN ACT CONCERNING DRUG AFFORDABILITY”) - (March 18, 2024)
RE: U.S. Senate Bipartisan 340B Working Group Request for Information – 340B Drug Pricing Program - (July 24, 2023)
RE: Louisiana House Bill 548 - 340B Drug Pricing Program - (June 7, 2023)
RE: CAG-00464N; Notice January 12, 2023; Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection - (February 9, 2023)
RE: HIV Community Concerns Over S.4395 - (August 15, 2022)
RE: COVID-19 Funding for District of Columbia Nonprofit Addiction Treatment & Mental Health Service Providers - (June 28, 2021)
RE: Needed Update to the Guide for HIV/AIDS Clinical Care - (Nov 21, 2016)
Letter from HIV/AIDS Bureau - (Dec 12, 2016)
RE: Medicare Part B Drug Payment Model
RE: Notice of Benefit and Payment Parameters & Essential Health Benefits
RE: FR Doc No: 2013-06031; Notice Mar 18, 2014; Patient Protection and Affordable Care Act; Third Party Payment of Qualified Health Plan Premiums
RE: FR Doc No: SSA-2007-0082, Revised Medical Criteria for Evaluating HIV Infection and for Evaluating Functional Limitations in Immune System Disorders
RE: FR Doc No: 2013-31473; Notice Jan 3, 2014; Affordable Care Act
RE: Federal Register 77 FR 800; Notice Jan 6, 2012; HRSA Study
RE: ADAP Waiting List Crisis Letter; Mr. Jeffrey Crowley, Director, Office of National AIDS Policy